Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Preliminary results of a phase II study of single agent Bay 80-6946, a Novel PI3K inhibitor, in patients with relapsed/refractory, indolent or aggressive lymphoma.

× No keyword cloud information.

6 in total

1. Mantle cell lymphoma: taking therapeutic advantage of new insights into the biology.

Authors: Tiffany Tang; Peter Martin
Journal: Curr Hematol Malig Rep Date: 2014-09 Impact factor: 3.952

Review 2. The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date.

Authors: Till Seiler; Grit Hutter; Martin Dreyling
Journal: Drugs Date: 2016-04 Impact factor: 9.546

Review 3. Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma.

Authors: Jason R Westin
Journal: Clin Lymphoma Myeloma Leuk Date: 2014-02-07

4. Pharmacokinetics of intravenous pan-class I phosphatidylinositol 3-kinase (PI3K) inhibitor [¹⁴C]copanlisib (BAY 80-6946) in a mass balance study in healthy male volunteers.

Authors: Michael Gerisch; Thomas Schwarz; Dieter Lang; Gabriele Rohde; Stefanie Reif; Isabelle Genvresse; Susanne Reschke; Dorina van der Mey; Camille Granvil
Journal: Cancer Chemother Pharmacol Date: 2017-07-11 Impact factor: 3.333

5. Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008).

Authors: Alessandro D Santin; Virginia Filiaci; Stefania Bellone; Elena S Ratner; Cara A Mathews; Guilherme Cantuaria; Camille C Gunderson; Teresa Rutledge; Barbara M Buttin; Heather A Lankes; Michael Frumovitz; Samir N Khleif; Warner K Huh; Michael J Birrer
Journal: Gynecol Oncol Rep Date: 2020-01-02

6. Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.

Authors: Anas Younes; Gilles Salles; Giovanni Martinelli; Robert Gregory Bociek; Dolores Caballero Barrigon; Eva González Barca; Mehmet Turgut; John Gerecitano; Oliver Kong; Chaitali Babanrao Pisal; Ranjana Tavorath; Won Seog Kim
Journal: Haematologica Date: 2017-09-29 Impact factor: 9.941